HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts

M. Faehling, D. Anders, M. Hetzel, V. Hombach, M. Bachem (Esslingen, Stuttgart, Ulm, Germany)

Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session: Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session type: Thematic Poster Session
Number: 1870
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Faehling, D. Anders, M. Hetzel, V. Hombach, M. Bachem (Esslingen, Stuttgart, Ulm, Germany). HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts. Eur Respir J 2008; 32: Suppl. 52, 1870

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003

BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006



Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Simultaneous mRNA expression analysis of transforming growth factor β1 and three types of TGF-β receptors in broncho-alveolar lavage cells from patients with interstitial lung diseases – the pilot study
Source: Eur Respir J 2003; 22: Suppl. 45, 223s
Year: 2003

The expression of IL-5, GM-CSF mRNA and its modulation by dexamethasone in lung tissue and esoinohils of bronchoalveolar lavage fluid from allergic guinea-pigs
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001

Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009


Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003

Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005

Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Elevated level of tissue inhibitor of metalloproteinase 1 in bronchoalveolar lavage fluid in fibrosing lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007